Search

Your search keyword '"Carlos Grande"' showing total 5 results
Start Over Author "Carlos Grande" Journal hematological oncology
5 results on '"Carlos Grande"'

1. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment

Author

Ana Jiménez-Ubieto, Laura Magnano, Pilar Martínez-Sánchez, Elena Pérez, Carmen Marrero, Carmen Albo, Javier Lopez Jimenez, Santiago Mercadal, María Manzanares, Isidro Jarque, Reyes Arranz, Lucrecia Yáñez, Alejandro Martín, Juan José Lahuerta, Carlos Vallejo, Carlos Grande, Antonio Salar, José Javier Ferreiro, Miguel T. Hernández-García, Dolores Caballero, Luis Palomera, José M. Moraleda, Armando López-Guillermo, Sabela Bobillo, Andrea Galeo, Erika Coria, and Silvana Novelli

Subjects
Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Follicular lymphoma, Early Relapse, Early Therapy, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Internal medicine, medicine, Humans, Registries, Autografts, Lymphoma, Follicular, Complete response, Aged, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, General Medicine, Middle Aged, medicine.disease, Rescue treatment, Survival Rate, Spain, 030220 oncology & carcinogenesis, Female, Rituximab, business, 030215 immunology
Published
2018

2. RESULTS OF PHASE II STUDY OF COMBINED IMMUNOTHERAPY WITH RITUXIMAB PLUS LYMPHOKINE-ACTIVATED KILLER CELLS AS MAINTENANCE IN FOLLICULAR LYMPHOMA PATIENTS

Author

T. Olave, A. Panizo, M. Rodriguez, N. Martinez Calle, J. Nuñez, Pilar Giraldo, A. Diaz De Cerio, Marcio Andrade-Campos, R. Garcia Muñoz, J. Feliu, Carlos Grande, Susana Inogés, E. Bandres, Carlos Panizo, and Esther Pena

Subjects
Cancer Research, Lymphokine-activated killer cell, business.industry, medicine.medical_treatment, Follicular lymphoma, Phases of clinical research, Hematology, General Medicine, Immunotherapy, medicine.disease, Oncology, medicine, Cancer research, Rituximab, business, medicine.drug
Published
2019

3. PHASE 2 RANDOMIZED TRIAL COMPARING STANDARD RCHOP VERSUS BRCAP AS FIRST LINE TREATMENT IN YOUNG PATIENTS WITH HIGH-RISK DLBCL. A STUDY FROM SPANISH GROUP GELTAMO

Author

Santiago Mercadal, Alejandro Martín, Isidro Jarque, Armando López-Guillermo, Juan-Manuel Sancho, Carlos Grande, Javier Lopez, Francisco-Javier Peñalver, J. Bargay, Carmen Albo, Maria J. Rodriguez-Salazar, Santiago Montes-Moreno, Concepción Nicolás, Estrella Carrillo, Jose Maria Roncero, Miguel Canales, Mónica Coronado, Eva González-Barca, José-Ángel Hernández, Luis Palomera, Eulogio Conde, Dolores Caballero, María José Ramírez, and J. Perez De Oteyza

Subjects
Cancer Research, medicine.medical_specialty, business.industry, Hematology, General Medicine, law.invention, First line treatment, 03 medical and health sciences, 0302 clinical medicine, Oncology, Randomized controlled trial, law, Group (periodic table), 030220 oncology & carcinogenesis, Internal medicine, Physical therapy, medicine, business, 030215 immunology
Published
2017

4. LONG-TERM RESULTS OF THE MULTICENTER PHASE II TRIAL WITH BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT FOR PATIENTS WITH MALT LYMPHOMA (MALT-2008-01)

Author

F.J. Peñalver, Carlos Montalbán, J. Bargay, Juan F. García, Antonio Salar, Carlos Grande, Carlos Panizo, Jose Francisco Tomas, Juan-Manuel Sancho, Miguel Canales, Eulogio Conde, Luis Palomera, Reyes Arranz, J. L. Bello, M. T. Garcia, Eva Domingo-Domenech, Dolores Caballero, Ana Muntañola, M. Rodriguez, Concepción Nicolás, and J. J. Sanchez-blanco

Subjects
0301 basic medicine, Oncology, Bendamustine, Cancer Research, medicine.medical_specialty, business.industry, MALT lymphoma, Hematology, General Medicine, Long term results, medicine.disease, First line treatment, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, Rituximab, business, medicine.drug
Published
2017

5. Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from the Spanish group GELTAMO

Author

Alejandro Martín, G. Rodríguez, Antonio Salar, Eva González-Barca, Ivan Dlouhy, Armando López-Guillermo, M. Espeso, E. Campo, Isidro Jarque, Juan-Manuel Sancho, Juan-Miguel Bergua, Mónica Baile, Dolores Caballero, Carlos Grande, and Santiago Montes-Moreno

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, Phases of clinical research, Hematology, General Medicine, Internal medicine, medicine, Refractory Diffuse Large B-Cell Lymphoma, In patient, ESHAP, business, Lenalidomide, medicine.drug
Published
2017

Catalog

Books, media, physical & digital resources
See catalog results